Dermal and cortical expansion Target opportunities in cortical bone products and expandable interbody devices, leveraging Spine Wave's Tempest demineralized cortical fibers and Exceed expandable interbody platforms to address surgeons seeking less invasive, high-differentiation implants.

Robotics and navigation Capitalize on the collaboration with eCential Robotics to position Spine Wave's solutions within robotics-assisted spine procedures, offering integrated instrumentation, navigation, and imaging to surgeons pursuing precision and efficiency gains.

Surgeon-driven pipeline Leverage the surgeon-driven product development approach to co-create and pilot new expandable and nucleus augmentation products with high clinical relevance, aligning sales outreach with ongoing trials and early adopters.

Mid-market potential Focus on hospitals and regional players with growing spine programs, given Spine Wave's mid-market scale (51-200 employees) and revenue in the lower tens of millions, presenting a compelling value proposition against larger incumbents.

Growth platform Highlight recent product launches (Tempest DCF fibers, Exceed TiCell surface technology) as proof points for innovation-led growth, offering cross-sell opportunities across interbody devices, allograft materials, and surface tech enhancements.